Search PubMed⌕ Search

Biomedical subjects

R Renaud

Publications and source records attributed to R Renaud.

133 records · Page 8Linked to original sources
PubMedDate not supplied

[The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].

The efficacy of veralipride, a new non-hormonal treatment for the treatment of menopausal symptoms, was evaluated following a randomised comparative study with a commonly used non-hormonal drug, bêta-alanine. Two groups of patients between 53 and 59 years received, one veralipride (22) at a dose of 100 mg/day for 20 days, the other beta-alanine (21) during the same period. 14 patients noted an improvement in their hot flushes while receiving veralipride as against 4 receiving beta-alanine. The superiority of veralipride was quite significant (P less than 0.01). Both products were well tolerated.

Adult↗
PubMedDate not supplied

[Simultaneous study of the placental, myometrial and cervical circulations (indium 113 and anemometric thermometry). 3). Double blind study of the action of intravenous ritodrine during normal pregnancy].

The authors measure the changes in placental and myometrial blood flow using an isotope technique with Indium 113. They calculate an index of the variation in placental blood flow (I.V. D.P.) and an index of variation of myomoetfrial blood flow (I.V.D.M.) after injecting Ritodrine or a placebo between the 28th and the 36th week of pregnancy. This study was carried out in 26 normal women. At the same time using Brotanek's technique changes in the cervical blood flow were registered. No change in the placental, myometrial or cervical blood flows were noted while Ritodrine was being transfused intravenously.

Adult↗
PubMedDate not supplied

[Conservative radiosurgical treatment in in situ ductal cancer of the breast. Analysis of 86 cases].

OBJECTIVES: With effective screening programmes, the global incidence of in situ ductal carcinoma of the breast has risen to 15%, representing 20 to 30% of the mammographically detected T0 tumours. Prognosis is generally good in these tumours, but treatment has in the past, paradoxically, relied on extensive surgery. We report our experience with conservative radiosurgery performed in such cases from 1980 to 1990. METHODS: There were 86 patients with a mean age of 52 years. Initial TNM classification was T0 = 57, T1 = 17, T2 = 9 and Tx = 3. All underwent limited surgery (quadrantectomy: 17; lumpectomy: 69) and 49 had axillary dissection. All received breast irradiation with scar boost (46-50 Gy + 10-14 Gy with classical fractionation). Thirty one postmenopausal women received adjuvant tamoxifen. The quality of the resection was good in 77 cases, doubtful or incomplete in 9. In one case axillary nodal involvement was found. The histological subtype was clearly identified in 63 cases. With a median follow-up of 58 months, 3 local relapses occurred (3.4%), at 27, 48 and 52 months respectively. One was in situ and two invasive. All were clinical lesions (2 T1 and 1 T2); two had incomplete or doubtful excision and all received less than 60 Gy on the tumour bed. All had mastectomy. Two are alive and well but one developed multiple metastasis. Five other women had subsequent surgery for suspicion of local relapse but all had benign disease. One developed contralateral disease 20 months later. Two women died subsequently due to a second cancer. CONCLUSION: These results confirm the importance of the excision quality and suggests a possible dose-effect in the control of in situ ductal carcinoma by radiotherapy. The recent results of the B-17 NSBAP trial also conclude that the radiosurgical conservative treatment, for limited in situ ductal carcinoma, is a reasonable alternative to mastectomy.

Adult↗